Therabel grows its products portfolio mostly through partnerships on new, close-to-market or marketed products in the major European countries.
Our objective is to establish long term partnerships in order to maximize the potential of partnered products through ethical and creative promotional approaches.
We have a solid track record of managing different types of partnerships, including European-wide product licenses, distribution agreements, Joint-Ventures, co-marketing agreements, co-promotion agreements …
While our main therapeutic focus is currently on cardiology, pain, supportive care, respiratory, urology and gastroenterology, we follow an opportunistic approach and can consider partnering on products to which we can bring substantial value (pharmaceutical products including Rx and OTC, medical devices, diagnostic solutions, food supplements…).